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Somatomedin activity and hGH levels were measured in blood samples taken simultaneously from the hepatic vein and the peripheral vein in 18 alcoholic patients with cirrhosis and in 10 adult patients without liver disease. In patients with cirrhosis, the somatomedin activity, measured in the hepatic vein, was significantly lower than in normal subjects (P < 0.001), although growth hormone levels were higher (P < 0.01). The hepatic blood flow was measured in 16 out of 28 subjects. In patients with cirrhosis a significant correlation was found between somatomedin activity and hepatic blood flow (n = 10, r = 0.682, P < 0.05). Sci., 21, [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] 
